SEC Form 4 · accession 0001140361-15-020701
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary A Lyons
Director
Period of report
May 8, 2015
Accepted (ET)
May 18, 2015 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock Award (Common Stock)F1,F2 | May 8, 2015 | A | 12,440 | $0.00 | A | 12,440 | D | |
| Common Stock | holding | — | — | — | 24,409 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Restricted Stock Award ("Award" was granted to the board members in lieu of cash fees payable pursuant to the Director Compensation Plan. The Award vests in full on December 31, 2015, subject to continued service as a Director.
- F2The present Form 4 was not filed within 2 business days of the transaction date.